Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

13.72
Delayed Data
As of 3:59pm ET
 -0.08 / -0.58%
Today’s Change
12.45
Today|||52-Week Range
22.48
-30.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues89.5M104.6M126.4M105.6M
 
 
 
 
 
Cost of Goods Sold58.4M73.3M84.1M70.8M
 
 
 
 
 
Depreciation And Amortization6.3M6.9M8.4M8.5M
 
 
 
 
 
 
Operating ExpensesGross Income24.9M24.4M33.9M26.2M
 
 
 
 
 
General Expenses17.1M23.1M24.9M27.8M
 
 
 
 
 
Research And Development384.0K1.9M2.7M3.2M
 
 
 
 
 
Total Operating Expenses81.7M103.3M117.4M107.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income7.8M1.3M9.0M-1.6M
 
 
 
 
 
Extraordinary Charge-1.6M-1.2M-2.8M-2.6M
 
 
 
 
 
Interest Expense On Debt3.2M6.3M6.8M7.1M
 
 
 
 
 
Other Expenses634.0K798.0K319.0K-997.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.6M-5.5M-245.0K-12.3M
 
 
 
 
 
Income Taxes-1.3M-1.3M-2.0M-2.2M
 
 
 
 
 
Net Income2.3M-4.2M1.8M-10.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS32.1M34.1M35.6M34.7M
 
 
 
 
 
Shares To Calculate EPS Diluted33.2M34.1M35.6M34.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.07-$0.12$0.05-$0.29
 
 
 
 
 
EPS Diluted$0.07-$0.12$0.05-$0.29